FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stefan Bielack

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Living Beings

Infants

Geographic Areas

Germany

Co-author Network

Publications

TOP 3
Stefan S Bielack; L Kager; Beate Kempf-Bielack; R Schwarz; T Von Kalle; T Wirth; J Whelan
Controversies in childhood osteosarcoma.
Tobias M Dantonello; Stefan Gfroerer; Peter Kaatsch; Thomas Klingebiel; Ewa Koscielniak; Stefanie Kube; Ivo Leuschner; Gustaf Ljungman; Michaela Nathrath; Niklas Pal; Andreas Schuck; Christian Vokuhl; Benedikt Bernbeck; Stefan S Bielack
Malignant ectomesenchymoma in children and adolescents: report from the Cooperative Weichteilsarkom Studiengruppe (CWS).
Sabine Stegmaier; Ivo Leuschner; Stefan S Bielack; Thomas Klingebiel; Ewa Koscielniak
Questionable universal validity of PAX3/FOXO1 fusion gene status as molecular marker for improvement of risk stratification in rhabdomyosarcoma therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stefan Bielack (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Stefan S Bielack; L Kager; Beate Kempf-Bielack; R Schwarz; T Von Kalle; T Wirth; J Whelan
Controversies in childhood osteosarcoma.
Minerva pediatrica 2013;65(2):125-48.
2013: Tobias M Dantonello; Stefan Gfroerer; Peter Kaatsch; Thomas Klingebiel; Ewa Koscielniak; Stefanie Kube; Ivo Leuschner; Gustaf Ljungman; Michaela Nathrath; Niklas Pal; Andreas Schuck; Christian Vokuhl; Benedikt Bernbeck; Stefan S Bielack
Malignant ectomesenchymoma in children and adolescents: report from the Cooperative Weichteilsarkom Studiengruppe (CWS).
Pediatric blood & cancer 2013;60(2):224-9.
2012: Sabine Stegmaier; Ivo Leuschner; Stefan S Bielack; Thomas Klingebiel; Ewa Koscielniak
Questionable universal validity of PAX3/FOXO1 fusion gene status as molecular marker for improvement of risk stratification in rhabdomyosarcoma therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(32):4039-40; author reply 4040-1.
2011: Sabine Stegmaier; Ivo Leuschner; Christopher Poremba; Karl-Ludwig Schaefer; Albert N Békássy; Stefan S Bielack; Bernarda Kazanowska; Thomas Klingebiel; Ewa Koscielniak
Prognostic value of PAX-FKHR fusion status in alveolar rhabdomyosarcoma: a report from the cooperative soft tissue sarcoma study group (CWS).
Pediatric blood & cancer 2011;57(3):406-14.
2011: Stefan S Bielack; Neyssa M Marina; Mark Bernstein
High-intensity focused ultrasound (HIFU) is not indicated for treatment of primary bone sarcomas.
Cancer 2011;117(12):2822; author reply 2822-3.
2011: Tobias M Dantonello; Peter Winkler; Tobias Boelling; Godehard Friedel; Irene Schmid; Adrian C Mattke; Gustaf Ljungman; Stefan S Bielack; Thomas Klingebiel; Ewa Koscielniak
Embryonal rhabdomyosarcoma with metastases confined to the lungs: report from the CWS Study Group.
Pediatric blood & cancer 2011;56(5):725-32.
2011: Marios Paulides; Wolfgang Stöhr; Hans-Jürgen Laws; Norbert Graf; Max Lakomek; Frank Berthold; Klaus Schmitt; Felix Niggli; Heribert Jürgens; Stefan S Bielack; Ewa Koscielniak; Thomas Klingebiel; Thorsten Langer
Antibody levels against tetanus and diphtheria after polychemotherapy for childhood sarcoma: a report from the Late Effects Surveillance System.
Vaccine 2011;29(8):1565-8.
2011: Jana Ellegast; Thomas F E Barth; Michael Schulte; Stefan S Bielack; Mathias Schmid; Regine Mayer-Steinacker
Metastasis of osteosarcoma after 16 years.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(3):e62-6.
2010: Leo Kager; Andreas Zoubek; Martin Dominkus; Susanna Lang; Nicole Bodmer; Gernot Jundt; Thomas Klingebiel; Heribert Jürgens; Helmut Gadner; Stefan S Bielack
Osteosarcoma in very young children: experience of the Cooperative Osteosarcoma Study Group.
Cancer 2010;116(22):5316-24.
2010: J Ritter; Stefan S Bielack
Osteosarcoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21 Suppl 7():vii320-5.
2010: Stefan S Bielack
Osteosarcoma: time to move on?
European journal of cancer (Oxford, England : 1990) 2010;46(11):1942-5.
2010: Stefan S Bielack; Markus Franke
Re: Late recurrence in pediatric cancer: a report from the childhood cancer survivor study.
Journal of the National Cancer Institute 2010;102(11):828; author reply 828-9.
2010: P C W Hogendoorn; N Athanasou; Stefan S Bielack; E De Alava; A P Dei Tos; S Ferrari; Hans Gelderblom; R Grimer; K Sundby Hall; B Hassan; P C W Hogendoorn; H Jurgens; M Paulussen; Leida B Rozeman; A H M Taminiau; J Whelan; D Vanel
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21 Suppl 5():v204-13.
2010: Thomas G P Grunewald; Irene von Luettichau; Gregor Weirich; Angela Wawer; Uta Behrends; Peter M Prodinger; Gernot Jundt; Stefan S Bielack; Reiner Gradinger; Stefan Burdach
Sclerosing epithelioid fibrosarcoma of the bone: a case report of high resistance to chemotherapy and a survey of the literature.
Sarcoma 2010;2010():431627.
2009: Tobias M Dantonello; Christoph Int-Veen; Dieter Harms; Ivo Leuschner; Bernhard F Schmidt; Manfred Herbst; Heribert Juergens; Hans-Gerhard Scheel-Walter; Stefan S Bielack; Thomas Klingebiel; Roswita Dickerhoff; Sylvia Kirsch; Ines Brecht; Rainer Schmelzle; Michael Greulich; Helmut Gadner; Jeanette Greiner; Ildiko Marky; Jörn Treuner; Ewa Koscielniak
Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(9):1446-55.
2009: Susanne Heinsohn; Miklós Szendrői; Stefan S Bielack; Udo Zur Stadt; Hartmut Kabisch
Evaluation of SV40 in osteosarcoma and healthy population: a Hungarian-German study.
Oncology reports 2009;21(2):289-97.
2009: Stefan S Bielack; Beate Kempf-Bielack; Detlev Branscheid; Dorothe Carrle; Godehard Friedel; Knut Helmke; Matthias Kevric; Gernot Jundt; Thomas Kühne; Rainer Maas; Rudolf Schwarz; Andreas Zoubek; Heribert Jürgens
Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(4):557-65.
2009: Stefan S Bielack; Herbert Jürgens; Gernot Jundt; Matthias Kevric; Thomas Kühne; Peter Reichardt; Andreas Zoubek; Mathias Werner; Winfried Winkelmann; Rainer Kotz
Osteosarcoma: the COSS experience.
Cancer treatment and research 2009;152():289-308.
2009: Dorothe Carrle; Stefan S Bielack
Osteosarcoma lung metastases detection and principles of multimodal therapy.
Cancer treatment and research 2009;152():165-84.
2009: Rudolf Schwarz; Oyvind Bruland; Anna Cassoni; Paula Schomberg; Stefan S Bielack
The role of radiotherapy in oseosarcoma.
Cancer treatment and research 2009;152():147-64.
2008: Christian Kersting; Konstantin Agelopoulos; Hartmut Schmidt; Eberhard Korsching; Christian August; Georg Gosheger; Uta Dirksen; Herbert Juergens; Winfried Winkelmann; Burkhard Brandt; Stefan S Bielack; Horst Buerger; Carsten Gebert
Biological importance of a polymorphic CA sequence within intron 1 of the epidermal growth factor receptor gene (EGFR) in high grade central osteosarcomas.
Genes, chromosomes & cancer 2008;47(8):657-64.
2008: Stefan S Bielack; Neyssa M Marina; Stefano Ferrari; Lee Helman; Sigbjørn Smeland; Jeremy S Whelan; Gregory H Reaman
Osteosarcoma: the same old drugs or more?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):3102-3; author reply 3104-5.
2008: Tobias M Dantonello; Christoph Int-Veen; Ivo Leuschner; Andreas Schuck; Rhoikos Furtwaengler; Alexander Claviez; Dominik Schneider; Thomas Klingebiel; Stefan S Bielack; Ewa Koscielniak
Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups.
Cancer 2008;112(11):2424-31.
2008: Sven Jasnau; Ulrich Meyer; Jenny Potratz; Gernot Jundt; Matthias Kevric; Ulrich Joos; Heribert Jürgens; Stefan S Bielack
Craniofacial osteosarcoma Experience of the cooperative German-Austrian-Swiss osteosarcoma study group.
Oral oncology 2008;44(3):286-94.
2008: Stefan S Bielack; Dorothe Carrle; Jendrik Hardes; Andreas Schuck; Michael Paulussen
Bone tumors in adolescents and young adults.
Current treatment options in oncology 2008;9(1):67-80.
2008: Tobias M Dantonello; Christoph Int-Veen; Peter Winkler; Ivo Leuschner; Andreas Schuck; Bernhard F Schmidt; Helmut Lochbuehler; Sylvia Kirsch; Erika Hallmen; Iris Veit-Friedrich; Stefan S Bielack; Felix K Niggli; Bernarda Kazanowska; Ruth Ladenstein; Thomas Wiebe; Thomas Klingebiel; Jörn Treuner; Ewa Koscielniak
Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):406-13.
2007: Annika Unruh; Guido Fitze; Ute Jänig; Stefan S Bielack; Helmut Lochbühler; Wiltrud Coerdt
Medullary thyroid carcinoma in a 2-month-old male with multiple endocrine neoplasia 2B and symptoms of pseudo-Hirschsprung disease: a case report.
Journal of pediatric surgery 2007;42(9):1623-6.
2007: Christian Kersting; Carsten Gebert; Konstantin Agelopoulos; Hartmut Schmidt; Paulus van Diest; Herbert Juergens; Winfried Winkelmann; Matthias Kevric; Georg Gosheger; Burkhard Brandt; Stefan S Bielack; Horst Buerger
Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(10):2998-3005.
2007: Susanne Heinsohn; Ulrike Evermann; Udo zur Stadt; Stefan S Bielack; Hartmut Kabisch
Determination of the prognostic value of loss of heterozygosity at the retinoblastoma gene in osteosarcoma.
International journal of oncology 2007;30(5):1205-14.
2007: Marios Paulides; H G Dörr; Wolfgang Stöhr; Stefan S Bielack; Ewa Koscielniak; T Klingebiel; Heribert Jürgens; Tobias Bölling; Normann Willich; R Sauer; Thorsten Langer; Jörn D Beck
Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System.
Clinical endocrinology 2007;66(5):727-31.
2007: Wolfgang Stöhr; Marios Paulides; Stefan S Bielack; Heribert Jürgens; Jörn Treuner; Rainer Rossi; Thorsten Langer; Jörn D Beck
Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System.
Pediatric blood & cancer 2007;48(4):447-52.
2007: Wolfgang Stöhr; Marios Paulides; Stefan S Bielack; Heribert Jürgens; Ewa Koscielniak; Rainer Rossi; Thorsten Langer; Jörn D Beck
Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system.
Pediatric blood & cancer 2007;48(2):140-7.
2006: Dorothe Carrle; Stefan S Bielack
Current strategies of chemotherapy in osteosarcoma.
International orthopaedics 2006;30(6):445-51.
2006: Charles A Stiller; Stefan S Bielack; Gernot Jundt; Eva Steliarova-Foucher
Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project.
European journal of cancer (Oxford, England : 1990) 2006;42(13):2124-35.
2006: Carsten Gebert; Christian Brinkschmidt; Stefan S Bielack; Thomas Bernhardt; Heribert Jürgens; Werner Böcker; Winfried Winkelmann; Horst Bürger; Georg Gosheger
The potential of comparative genomic hybridization as a tool in the differential diagnosis of matrix-producing bone lesions.
International journal of surgical pathology 2006;14(3):187-92.
2006: Merle Eselgrim; Henrike Grunert; Thomas Kühne; Andreas Zoubek; Matthias Kevric; Horst Bürger; Heribert Jürgens; Regine Mayer-Steinacker; Georg Gosheger; Stefan S Bielack
Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials.
Pediatric blood & cancer 2006;47(1):42-50.
2006: Leo Kager; Andreas Zoubek; Ulrike Kastner; Beate Kempf-Bielack; Jenny Potratz; Rainer Kotz; G Ulrich Exner; Christiane Franzius; Susanna Lang; Rainer Maas; Heribert Jürgens; Helmut Gadner; Stefan S Bielack
Skip metastases in osteosarcoma: experience of the Cooperative Osteosarcoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(10):1535-41.
2006: Marios Paulides; Anja Kremers; Wolfgang Stöhr; Stefan S Bielack; Heribert Jürgens; Jörn Treuner; Jörn D Beck; Thorsten Langer
Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS).
Pediatric blood & cancer 2006;46(4):489-95.
2006: Marios Paulides; Wolfgang Stöhr; Stefan S Bielack; Heribert Jürgens; Ewa Koscielniak; Thomas Klingebiel; Robert Zimmermann; Daniel Stachel; Thorsten Langer; Jörn D Beck
Prospective evaluation of hepatitis B, C and HIV infections as possible sequelae of antineoplastic treatment in paediatric sarcoma patients: a report from the Late Effects Surveillance System.
Oncology reports 2006;15(3):687-91.
2006: Esther Hauben; Stefan S Bielack; R Grimer; Gernot Jundt; P Reichardt; Matthew R Sydes; Antonie H M Taminiau; Pancras Hogendoorn
Clinico-histologic parameters of osteosarcoma patients with late relapse.
European journal of cancer (Oxford, England : 1990) 2006;42(4):460-6.
2005: Robert J Grimer; Stefan S Bielack; Silke Flege; Stephen R Cannon; Gunnar Foleras; Ivan Andreeff; Todor Sokolov; Antonie H M Taminiau; Martin Dominkus; Mikel San-Julian; Yehuda Kollender; Georg Gosheger
Periosteal osteosarcoma--a European review of outcome.
European journal of cancer (Oxford, England : 1990) 2005;41(18):2806-11.
2005: Katja Masjosthusmann; Stefan S Bielack; Gabriele Köhler; Annekathrein Florax; Manfred Schiborr; Jochen Bruch; Dirk Reinhardt; Nanna Kuhn; Michael Paulussen; Heribert Jürgens
Concomitant Ewing sarcoma and acute lymphoblastic leukemia in a 5-year-old girl.
Pediatric blood & cancer 2005;45(6):846-9.
2005: Sing Yu Goldstein-Jackson; Georg Gosheger; Günter Delling; Wolfgang E Berdel; G Ulrich Exner; Gernot Jundt; Jan-Nicolas Machatschek; Andreas Zoubek; Heribert Jürgens; Stefan S Bielack
Extraskeletal osteosarcoma has a favourable prognosis when treated like conventional osteosarcoma.
Journal of cancer research and clinical oncology 2005;131(8):520-6.
2005: Wolfgang Daecke; Stefan S Bielack; Abdul-Kader Martini; Volker Ewerbeck; Heribert Jürgens; Rainer Kotz; Winfried Winkelmann; Hartmut Kabisch; Matthias Kevric; Ludger Bernd
Osteosarcoma of the hand and forearm: experience of the Cooperative Osteosarcoma Study Group.
Annals of surgical oncology 2005;12(4):322-31.
2005: Beate Kempf-Bielack; Stefan S Bielack; Heribert Jürgens; Detlev Branscheid; Wolfgang E Berdel; G Ulrich Exner; Ulrich Göbel; Knut Helmke; Gernot Jundt; Hartmut Kabisch; Matthias Kevric; Thomas Klingebiel; Rainer Kotz; Rainer Maas; Rudolf Schwarz; Michael Semik; Jörn Treuner; Andreas Zoubek; Kurt Winkler
Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):559-68.
2004: Michael Kreuter; Ralf Bieker; Stefan S Bielack; Tanja Auras; Horst Buerger; Georg Gosheger; Heribert Jurgens; Wolfgang E Berdel; Rolf M Mesters
Prognostic relevance of increased angiogenesis in osteosarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8531-7.
2004: Silke Flege; Stefan S Bielack
[Goal and results of the COSS study].
Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft für Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft für Mikrochirurgie der Peripheren Nerven und Gefässe : Organ der Vereinigung der Deutschen Plastischen Chirurgen 2004;36(5):282-8.
2004: Stefan S Bielack; Heribert Jürgens
Surgical expertise and outcome in osteosarcoma trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2511; author reply 2511-3.
2004: Stefan S Bielack; Jan-Nicolas Machatschek; Silke Flege; Heribert Jürgens
Delaying surgery with chemotherapy for osteosarcoma of the extremities.
Expert opinion on pharmacotherapy 2004;5(6):1243-56.
2004: Benedikt Leidinger; Stefan S Bielack; G Koehler; Volker Vieth; Winfried Winkelmann; Georg Gosheger
High level of beta-hCG simulating pregnancy in recurrent osteosarcoma: case report and review of literature.
Journal of cancer research and clinical oncology 2004;130(6):357-61.
2004: BRIGITTE WIDEMANN; FRANK BALIS; Beate Kempf-Bielack; Stefan S Bielack; Charles B Pratt; Stefano Ferrari; Gaetano Bacci; Alan W Craft; Peter Charles Adamson
High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
Cancer 2004;100(10):2222-32.
2004: Thorsten Langer; Wolfgang Stöhr; Stefan S Bielack; Michael Paulussen; Jörn Treuner; Jörn D Beck
Late effects surveillance system for sarcoma patients.
Pediatric blood & cancer 2004;42(4):373-9.
2004: Stefan S Bielack; Michael Paulussen; Gabriele Köhler
A patient with two Ewing's sarcomas with distinct EWS fusion transcripts.
The New England journal of medicine 2004;350(13):1364-5.
2003: Silke Flege; Michaela Kuhlen; Michael Paulussen; Stefan S Bielack; Heribert Jürgens
[Surgery of primary malignant bone tumors].
Der Orthopäde 2003;32(11):940-8.
2003: Stefan S Bielack; Marie Dominique Tabone
Osteosarcomas occurring as second malignant neoplasms.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;68(1):89.
2003: Leo Kager; Andreas Zoubek; Ulrike Pötschger; Ulrike Kastner; Silke Flege; Beate Kempf-Bielack; Detlev Branscheid; Rainer Kotz; Mechthild Salzer-Kuntschik; Winfried Winkelmann; Gernot Jundt; Hartmut Kabisch; Peter Reichardt; Heribert Jürgens; Helmut Gadner; Stefan S Bielack
Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(10):2011-8.
2003: Stefan S Bielack; J S Rerin; Roswita Dickerhoff; Dagmar Dilloo; Bernhard Kremens; Arend von Stackelberg; Josef Vormoor; Heribert Jürgens
Osteosarcoma after allogeneic bone marrow transplantation. A report of four cases from the Cooperative Osteosarcoma Study Group (COSS).
Bone marrow transplantation 2003;31(5):353-9.
2003: Toshifumi Ozaki; Silke Flege; Matthias Kevric; Norbert Lindner; Rainer Maas; Günter Delling; Rudolf Schwarz; Arthur R von Hochstetter; Mechthild Salzer-Kuntschik; Wolfgang E Berdel; Heribert Jürgens; G Ulrich Exner; Peter Reichardt; Regine Mayer-Steinacker; Volker Ewerbeck; Rainer Kotz; Winfried Winkelmann; Stefan S Bielack
Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):334-41.
2003: Robert J Grimer; Stephen R Cannon; A M Taminiau; Stefan S Bielack; Beate Kempf-Bielack; R Windhager; Martin Dominkus; G Saeter; H Bauer; I Meller; Miklós Szendrői; G Folleras; Mikel San-Julian; J van der Eijken
Osteosarcoma over the age of forty.
European journal of cancer (Oxford, England : 1990) 2003;39(2):157-63.
2002: Toshifumi Ozaki; Karl-Ludwig Schaefer; Daniel Wai; Horst Buerger; Silke Flege; Norbert Lindner; Matthias Kevric; Raihanatou Diallo; Agnes Bankfalvi; Christian Brinkschmidt; Herbert Juergens; Winfried Winkelmann; Barbara Dockhorn-Dworniczak; Stefan S Bielack; Christopher Poremba
Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas.
International journal of cancer. Journal international du cancer 2002;102(4):355-65.
2002: Christiane Franzius; Stefan S Bielack; Silke Flege; Joachim Sciuk; Heribert Jürgens; Otmar Schober
Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(8):1012-7.
2002: Christine Franzius; Andreas Schuck; Stefan S Bielack
High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1953-4.
2002: Toshifumi Ozaki; Silke Flege; Ulf Liljenqvist; Axel Hillmann; Günter Delling; Mechthild Salzer-Kuntschik; Heribert Jürgens; Rainer Kotz; Winfried Winkelmann; Stefan S Bielack
Osteosarcoma of the spine: experience of the Cooperative Osteosarcoma Study Group.
Cancer 2002;94(4):1069-77.
2002: Stefan S Bielack; Beate Kempf-Bielack; Günter Delling; G Ulrich Exner; Silke Flege; Knut Helmke; Rainer Kotz; Mechthild Salzer-Kuntschik; Matthias Werner; Winfried Winkelmann; Andreas Zoubek; Heribert Jürgens; Kurt Winkler
Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):776-90.
2001: Christiane Franzius; Stefan S Bielack; Silke Flege; J Eckardt; Joachim Sciuk; Heribert Jürgens; Otmar Schober
High-activity samarium-153-EDTMP therapy followed by autologous peripheral blood stem cell support in unresectable osteosarcoma.
Nuklearmedizin. Nuclear medicine 2001;40(6):215-20.
2001: Axel Sauerbrey; Stefan S Bielack; Beate Kempf-Bielack; Andreas Zoubek; Michael Paulussen; Felix Zintl
High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma.
Bone marrow transplantation 2001;27(9):933-7.
2001: Christiane Franzius; HE Daldrup-Link; Joachim Sciuk; E J Rummeny; Stefan S Bielack; Heribert Jürgens; Otmar Schober
FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(4):479-86.
2000: Susanne Heinsohn; R B Scholz; B Weber; Birgit Wittenstein; Matthias Werner; Günter Delling; Beate Kempf-Bielack; P Setlak; Stefan S Bielack; Hartmut Kabisch
SV40 sequences in human osteosarcoma of German origin.
Anticancer research 2000;20(6B):4539-45.
1999: Ulrike Nowak-Göttl; N Münchow; U Klippel; Michael Paulussen; Stefan S Bielack; K Ullrich; Silke Ehrenforth
The course of fibrinolytic proteins in children with malignant bone tumours.
European journal of pediatrics 1999;158 Suppl 3():S151-3.
1999: Stefan S Bielack; A Schroeders; N Fuchs; G Bacci; H C Bauer; S Mapeli; B Tomeno; Kurt Winkler
Malignant fibrous histiocytoma of bone: a retrospective EMSOS study of 125 cases. European Musculo-Skeletal Oncology Society.
Acta orthopaedica Scandinavica 1999;70(4):353-60.
1999: Stefan S Bielack; Beate Kempf-Bielack; D Schwenzer; T Birkfellner; Günter Delling; Volker Ewerbeck; G Ulrich Exner; N Fuchs; Ulrich Göbel; Norbert Graf; U Heise; Knut Helmke; Arthur R von Hochstetter; Heribert Jürgens; Rainer Maas; N Münchow; Mechthild Salzer-Kuntschik; Jörn Treuner; Ursula Veltmann; Matthias Werner; Winfried Winkelmann; Andreas Zoubek; Rainer Kotz
[Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
Klinische Pädiatrie 1999;211(4):260-70.
1999: Axel R Zander; Tatjana Zabelina; Nicolaus Kröger; Helmut Renges; William H Krüger; C Löliger; Matthias Dürken; Marcus Stockschläder; Maike de Wit; G Wacker-Backhaus; Stefan S Bielack; N Jaburg; Bettina Rüssmann; Rudolf Erttmann; Hartmut Kabisch
Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow.
Bone marrow transplantation 1999;23(9):889-93.
1999: Stefan S Bielack; Beate Kempf-Bielack; U Heise; D Schwenzer; Kurt Winkler
Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1164.
1999: Christiane Franzius; Stefan S Bielack; Joachim Sciuk; B Vollet; Heribert Jürgens; Otmar Schober
High-activity samarium-153-EDTMP therapy in unresectable osteosarcoma.
Nuklearmedizin. Nuclear medicine 1999;38(8):337-40.
1998: Nicolaus Kröger; William H Krüger; G Wacker-Backhaus; Susanna Hegewisch-Becker; Marcus Stockschläder; N Fuchs; Bettina Rüssmann; Helmut Renges; Matthias Dürken; Stefan S Bielack; Maike de Wit; Gunter Schuch; H Bartels; Dietrich Braumann; Rolf Kuse; Hartmut Kabisch; Rudolf Erttmann; Axel R Zander
Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
Bone marrow transplantation 1998;22(11):1029-33.
1998: N Fuchs; Stefan S Bielack; D Epler; P Bieling; Günter Delling; Dieter Körholz; Norbert Graf; U Heise; Heribert Jürgens; Rainer Kotz; Mechthild Salzer-Kuntschik; P Weinel; Matthias Werner; Kurt Winkler
Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(8):893-9.
1996: Stefan S Bielack; Rudolf Erttmann; Beate Kempf-Bielack; Kurt Winkler
Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?
European journal of cancer (Oxford, England : 1990) 1996;32A(10):1652-60.
1996: P Bieling; N Rehan; P Winkler; K Helmke; R Maas; N Fuchs; Stefan S Bielack; U Heise; H Jurgens; Jörn Treuner; R Romanowski; U Exner; Rainer Kotz; Kurt Winkler
Tumor size and prognosis in aggressively treated osteosarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(3):848-58.
1996: Stefan S Bielack; Beate Kempf-Bielack; Kurt Winkler
Osteosarcoma: relationship of response to preoperative chemotherapy and type of surgery to local recurrence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):683-4.
1995: Stefan S Bielack; K Kallenbach; G Looft; Rudolf Erttmann; Kurt Winkler
Structurally modified anthracyclines retain activity in a cell line with simultaneous typical and atypical multidrug resistance.
Anticancer research 1995;15(4):1279-84.
1995: Stefan S Bielack; B Wulff; G Delling; Ulrich Göbel; Rainer Kotz; J Ritter; K Winkler
Osteosarcoma of the trunk treated by multimodal therapy: experience of the Cooperative Osteosarcoma study group (COSS).
Medical and pediatric oncology 1995;24(1):6-12.
1993: Stefan S Bielack; P Bieling; N Fuchs; K Winkler
[Bone tumors in children].
Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege / Deutsche Gesellschaft für Sozialpädiatrie und Deutsche Gesellschaft für Kinderheilkunde 1993;12(3):114-6.
1993: Stefan S Bielack; P Bieling; Rudolf Erttmann; Kurt Winkler
Intraarterial chemotherapy for osteosarcoma: does the result really justify the effort?
Cancer treatment and research 1993;62():85-92.
1993: K Winkler; Stefan S Bielack; G Delling; H Jürgens; R Kotz; Mechthild Salzer-Kuntschik
Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS).
Cancer treatment and research 1993;62():269-77.
1992: Kurt Winkler; P Bieling; Stefan S Bielack
[Chemotherapy of osteosarcoma].
Zeitschrift für Orthopädie und ihre Grenzgebiete 1992;130(4):285-9.
1991: Kurt Winkler; P Bieling; Stefan S Bielack; Günter Delling; C Dose; Heribert Jürgens; Rainer Kotz; J Ritter; Mechthild Salzer-Kuntschik
Local control and survival from the Cooperative Osteosarcoma Study Group studies of the German Society of Pediatric Oncology and the Vienna Bone Tumor Registry.
Clinical orthopaedics and related research 1991;(270):79-86.
1991: P Bieling; Stefan S Bielack; Günter Delling; Heribert Jürgens; Rainer Kotz; C Dose; H Astheimer; G Exner; H Gadner; Norbert Graf
[Neoadjuvant chemotherapy of osteosarcoma. Preliminary results of the cooperative COSS-86 osteosarcoma study].
Klinische Pädiatrie 1991;203(4):220-30.
1990: Kurt Winkler; Stefan S Bielack; Günter Delling; Mechthild Salzer-Kuntschik; Rainer Kotz; C Greenshaw; Heribert Jürgens; J Ritter; C Kusnierz-Glaz; Rudolf Erttmann
Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86).
Cancer 1990;66(8):1703-10.
1990: K Winkler; Stefan S Bielack; P Bieling
Osteosarcoma.
Current opinion in oncology 1990;2(3):486-90.
1990: Kurt Winkler; Stefan S Bielack; Günter Delling; Mechthild Salzer-Kuntschik; C Purfürst; U Heise; Heribert Jürgens; Rainer Kotz; Helmut Gadner; J Ritter
Intensified chemotherapy with ifosfamide (IFO) and influence of intraarterial (i.a.) versus intravenous (i.v.) infusion of cisplatinum (DDP). Preliminary results.
La Chirurgia degli organi di movimento 1990;75(1 Suppl):54-6.
1989: Stefan S Bielack; Rudolf Erttmann; K Winkler; G Landbeck
Doxorubicin: effect of different schedules on toxicity and anti-tumor efficacy.
European journal of cancer & clinical oncology 1989;25(5):873-82.
1989: Stefan S Bielack; Rudolf Erttmann; G Looft; C Purfürst; G Delling; Kurt Winkler; G Landbeck
Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma. Cooperative Osteosarcoma Study Group COSS.
Cancer chemotherapy and pharmacology 1989;24(6):376-80.
1986: R Erttmann; Stefan S Bielack; G Landbeck
Determination of 7-hydroxymethotrexate in human plasma by reversed phase high-performance liquid chromatography.
Oncology 1986;43(2):86-8.
1985: Rudolf Erttmann; Stefan S Bielack; G Landbeck
Kinetics of 7-hydroxy-methotrexate after high-dose methotrexate therapy.
Cancer chemotherapy and pharmacology 1985;15(2):101-4.
1985: Rudolf Erttmann; Stefan S Bielack; G Landbeck
7-Hydroxy-methotrexate and clinical toxicity following high-dose methotrexate therapy.
Journal of cancer research and clinical oncology 1985;109(1):86-8.